Procter & Gamble Health Ltd.

PGHL

Market Cap
₹8,687 Cr.
P/E
40.59

Procter & Gamble Health Ltd.

About
Procter & Gamble Health Limited, formerly known as Merck Limited, is a subsidiary of the Merck Group. Established in India in 1967, it went public in 1981 and operated in pharmaceuticals and chemicals… Read more
Procter & Gamble Health Limited, formerly known as Merck Limited, is a subsidiary of the Merck… Read more
Low
4637
52W Range
High
5643
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
30.56%
3yr Average
28.97%
5yr Average
33.88%
Net Profit Margin
Latest
18.66%
3yr Average
17.82%
5yr Average
34.2%
ROCE
Latest
20.27%
3yr Average
18.58%
5yr Average
17.15%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Revenue mix

Segment Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Drug Delivery Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    Peer Comparison
    Suppliers
    • Syngene International Ltd.
    • Piramal Enterprises Ltd.
    • AGI Greenpac Ltd.
    • Gulshan Polyols Ltd.
    • Empire Industries Ltd.
    FAQs on Procter & Gamble Health Ltd. Business

    Procter & Gamble Health Limited, formerly Merck Limited, is a leading healthcare company in India that expanded its operations through the acquisition of Merck's Consumer Health business in 2018.

    Procter&Gamble Healt major competitors are Strides Pharma Scien, Marksans Pharma, FDC, Orchid Pharma, Caplin Point Lab, Jubilant Pharmova, Wockhardt.
    Market Cap of Procter&Gamble Healt is ₹8,687 Crs.
    While the median market cap of its peers are ₹9,394 Crs.

    Procter&Gamble Healt seems to be less financially stable compared to its peers.
    Altman Z score of Procter&Gamble Healt is 5.2 and is ranked 5 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    timeline Timeline